… and the associated mortality risk. We evaluated the evidence of 42 … thromboembolism rates
of COVID-19 were significantly high. COVID-19 patients who developed thromboembolism …

… with COVID-19 can put patients at an increased risk of thrombosis. The total incidence of
thrombotic events in COVID-19 … Those with more severe disease and with other risk factors, …

… COVID‐19 have been reported. However, a definitive and robust estimate of the VTE risk in
patients with COVID‐19 … burden of VTE in patients with COVID‐19 is still not fully understood. …

… of venous thromboembolic events were diagnosed in COVID-19 … in COVID-19 patients
in the ICU. In the present study, we report on the incidence and risk factors of VTE in COVID-19 …

… has struggled to predict and mitigate this risk. We aimed to review available literature on
the risk and management of COVID-19 related venous thromboembolism (VTE), and provide …

… thromboembolic risk associated with COVID-19; (ii) what is the role and clinical relevance of
d-dimer in COVID-19 … a marginally increased risk of in-hospital mortality (relative risk 1·31; 95…

… coronavirus disease 2019 (COVID-19) is reported to be associated with a high risk of venous
thromboembolism (… risk of VTE in patients with COVID-19, timely identify the risk factors for …

… In this study, we performed an analysis of the cumulative incidence and risk of acute PE
and DVT among COVID-19 recovered patients. Over 8.5 months, acute PE and DVT were …

… with COVID-19 and VTE … COVID-19 are at high VTE risk despite prophylactic anticoagulation.
Further research should investigate the individualized VTE risk of patients with COVID-19 …

… The aim of this study was to compare VTE rates before and after COVID‐19 vaccination.
COVID‐19 vaccinated patients ≥18 years between November 1, 2020 through November 1, …